BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7084476)

  • 1. Platelet activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine). Activity of analogs lacking oxygen at the 2-position.
    Wykle RL; Surles JR; Piantadosi C; Salzer WL; O'Flaherty JT
    FEBS Lett; 1982 May; 141(1):29-32. PubMed ID: 7084476
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils.
    Wykle RL; Miller CH; Lewis JC; Schmitt JD; Smith JA; Surles JR; Piantadosi C; O'Flaherty JT
    Biochem Biophys Res Commun; 1981 Jun; 100(4):1651-8. PubMed ID: 7295320
    [No Abstract]   [Full Text] [Related]  

  • 3. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M; Coëffier E; Polonsky J; Benveniste J
    Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.
    O'Flaherty JT; Wykle RL; Miller CH; Lewis JC; Waite M; Bass DA; McCall CE; DeChatelet LR
    Am J Pathol; 1981 Apr; 103(1):70-8. PubMed ID: 7223864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues.
    Ostermann G; Kertscher HP; Lang A; Till U
    Thromb Res; 1986 Sep; 43(6):675-80. PubMed ID: 3764811
    [No Abstract]   [Full Text] [Related]  

  • 6. 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets.
    Lee TC; Malone B; Blank ML; Snyder F
    Biochem Biophys Res Commun; 1981 Oct; 102(4):1262-8. PubMed ID: 6797422
    [No Abstract]   [Full Text] [Related]  

  • 7. Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine.
    Namm DH; Tadepalli AS; High JA
    Thromb Res; 1982 Feb; 25(4):341-50. PubMed ID: 7071810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil responses to platelet-activating factor.
    O'Flaherty JT; Miller CH; Lewis JC; Wykle RL; Bass DA; McCall CE; Waite M; DeChatelet LR
    Inflammation; 1981 Sep; 5(3):193-201. PubMed ID: 7298160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.
    Satouchi K; Oda M; Saito K
    Lipids; 1987 Apr; 22(4):285-7. PubMed ID: 3110532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets.
    O'Flaherty JT; Salzer WL; Cousart S; McCall CE; Piantadosi C; Surles JR; Hammett MJ; Wykle RL
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):291-309. PubMed ID: 6844746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of alkyl ether chain length of acetyl glyceryl ether phosphorylcholine and its ethanolamine analog on biological activity toward rabbit platelets.
    Satouchi K; Pinckard RN; Hanahan DJ
    Arch Biochem Biophys; 1981 Oct; 211(2):683-8. PubMed ID: 7305392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
    Kertscher HP; Ostermann G
    Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G; Kertscher HP; Till U
    Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
    McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN
    J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues.
    Renooij W; Snyder F
    Biochim Biophys Acta; 1981 Feb; 663(2):545-56. PubMed ID: 6260215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
    Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
    Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain.
    Surles JR; Wykle RL; O'Flaherty JT; Salzer WL; Thomas MJ; Snyder F; Piantadosi C
    J Med Chem; 1985 Jan; 28(1):73-8. PubMed ID: 4038418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet activity of some prenylflavonoids.
    Lin CN; Shieh WL; Ko FN; Teng CM
    Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether).
    Ténce M; Michel E; Coeffier E; Polonsky J; Godfroid JJ; Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):558-9. PubMed ID: 7340440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.